Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Revenue projections:

Revenue projections for COO
Revenue projections for COO

COO is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.

Financial Ratios:

currentRatio 1.337000
forwardPE 12.218003
debtToEquity 33.201000
earningsGrowth 0.269000
revenueGrowth 0.062000
grossMargins 0.654440
operatingMargins 0.207790
trailingEps 2.010000
forwardEps 5.020460

COO's current ratio is 1.337, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting COO has no trouble covering its short-term financial obligations.
The Cooper Companies, Inc.'s Forward PE being in a reasonable range suggests the stock is fairly priced based on its earnings. The stock isn't overpriced, leaving room for growth, making it an attractive investment for those seeking opportunities for future value appreciation.
Positive gross and operating margins for The Cooper Companies, Inc. demonstrate the company's profitability. These margins reflect strong financial performance, with efficient operations contributing to the company's ability to generate consistent profits.
COO's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for COO's financial growth.

Price projections:

Price projections for COO
Price projections for COO

COO's current price concerning projections presents no discernible risks or opportunities. This balanced situation suggests a period of stability, where investors might consider holding their positions until more information becomes available.

Insider Transactions:

Insider Transactions for COO
Insider Transactions for COO


There were 7 transactions to buy COO stock, with market price of 75.8442851475307.The period under consideration saw no buy transactions.The current trend of more sells at COO's price levels may signal a potential decline. If this selling pressure continues, it could indicate investor pessimism, leading to more price drops in the future.

Recommendation changes over time:

Recommendations trend for COO
Recommendations trend for COO


Analysts' buy bias for COO signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to COO, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.